2014 Fiscal Year Final Research Report
Loss of PTEN is a predictive biomarker of trastuzumab resistance in HER2 overexpressed oesophago-gastric adenocarcinoma
| Project/Area Number |
24591940
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
HIROSHI Okabe 京都大学, 医学(系)研究科(研究院), その他 (10335250)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | 胃癌 / 化学療法 |
|---|
| Outline of Final Research Achievements |
Although previous clinical study showed significant effect of trastuzumab for HER2 overexpressed advanced oesophago-gastric adenocarcinoma, the response rate was less than 50%. This study aimed to identify a predictive biomarker of trastuzumab resistance.
In our study, PTEN loss is relatively frequent in HER2 overexpressed gastric cancer patients. PTEN loss might be a potential biomarker to select the HER2 overexpressed oesophago-gastric cancer patients who are less sensitive to the trastuzumab-based chemotherapy.
|
| Free Research Field |
医歯薬学
|
